Contact
Send comments to Erin Marie Daly at oxywatchdog@gmail.com.Follow
Oxy Watchdog’s Story
Find
Listen
Watch
Hot Topics
addiction Big Pharma Crime DEA Deaths doctors doctor shopping drug monitoring program education FDA heroin hydrocodone methadone naloxone Narcan narcotics OP Opana opiates opioid overdose overdoses oxy oxy-to-heroin oxycodone OxyContin pain clinics painkillers pain medication Percocet pharmaceutical pharmacy pill mills pills pills-to-heroin politics prescription drug abuse prescription drug monitoring program prescriptions Purdue Pharma Roxycodone Schedule II narcotics Teen deaths Vicodin XanaxBlogroll
- Addiction Journal
- An Addict In Our Son's Bedroom
- Awakening Through Love
- Breaking the Silence
- Diving Into the Mind of a Recovering Addict
- Hands Full of Tears
- Hurting Parents – Addicted Son
- Let Go Hang On
- Mom Trying To Detach With Love
- Mom vs. Heroin
- My Son is an Addict
- One Mom Talking
- OxyContin & Opiate Addiction: A Mother's Story
Resources
- Alliance of States with Prescription Monitoring Programs
- CASA Columbia
- Dispose My Meds
- Drugwatch.com
- Faces & Voices of Recovery
- Harm Reduction Coalition
- Henry's Fund
- NaloxoneInfo.org
- Narcotics Overdose Prevention and Education (NOPE Task Force)
- National Coalition Against Prescription Drug Abuse
- New Bridge Foundation's START Program
- NIDA – Commonly Abused Prescription Drugs
- No Heroin in Heaven
- Office of National Drug Control Policy – Prescription Drug Abuse
- Project J.O.S.H. (Journeying Onward Substance-Abuse Help)
- S.O.L.A.C.E. – Surviving Our Loss with Awareness, Compassion & Empathy
- SAMHSA
- Save A Star Drug Awareness Foundation
- Stop Drug Death
- TeensHealth – Prescription Drug Abuse
- The 11 Most Abused Prescription Drugs
- The D.O.P.E. Project (Drug Overdose Prevention and Education)
- The Medicine Abuse Project
- Time To Talk
- Treatment4Addiction
Categories
Archives
- February 2015
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
Tag Archives: Cardinal Health
DEA bans Walgreens from shipping Oxy in Fla.
The U.S. Drug Enforcement Agency has barred Walgreens from shipping oxycodone and other controlled drugs from its Jupiter, Fla., distribution center after finding that the company failed to maintain proper controls to ensure it didn’t dispense drugs to addicts and drug dealers.
According to the DEA, the distribution center has been the single largest distributor of oxycodone products in Florida since 2009. In 2011, 16 of the top 25 largest oxycodone purchasers by Walgreens retail pharmacies, including the top six purchasers, were in Florida and supplied by the Jupiter center, the agency said.
The strike against Walgreens comes just after the DEA revoked the controlled substances licenses for two CVS pharmacies in Sanford, Fla., after also accusing them of dispensing excessive amounts of oxycodone.
Separately in May, Cardinal Health reached a deal with the DEA that blocked its Lakeland, Fla. facility from distributing controlled substances for two years following similar accusations.
Posted in Informational, Pharmaceutical Industry, Policy & Regulation
Tagged Big Pharma, Cardinal Health, CVS, DEA, doctor shopping, narcotics, OxyContin, pain clinics, pain medication, painkillers, pharmaceutical, pharmacy, pill mills, prescription drug abuse, prescriptions, Schedule II narcotics, Walgreens
Leave a comment
Cardinal settles with DEA over painkiller distribution
Cardinal Health has reached a deal with the Drug Enforcement Administration that will block one of its Florida facilities from distributing controlled substances for two years. The company also said it will take steps to improve anti-diversion procedures designed to prevent prescription drugs from being abused.
Earlier this year, the DEA suspended Cardinal’s license after finding that the company – which is one of the nation’s largest distributors of pharmaceuticals – sold excessive amounts of oxycodone to four Florida pharmacies. (The suspension related only to the company’s license to distribute controlled substances from its Lakeland, Fla. facility, which the DEA claims shipped 50 times as much oxycodone to its top four customers than it has shipped to its other Florida retail customers.)
Cardinal challenged the suspension in federal court, and both the company and the DEA filed documents that gave an inside look into how prescription painkillers have flooded the black market.
Cardinal was initially granted a temporary restraining order blocking the suspension after convincing a judge that the move would disrupt drug shipments to more than 2,500 pharmacy customers in Florida, Georgia and South Carolina. The company said it has “robust controls and performs careful due diligence,” noting that in the past four years, it has stopped shipping controlled medicines to more than 350 pharmacies it determined posed an unreasonable risk of diversion, including 160 in Florida alone.
Posted in Crime, Litigation, Pharmaceutical Industry, Policy & Regulation
Tagged Big Pharma, Cardinal Health, Crime, DEA, hydrocodone, narcotics, opiates, oxy, oxycodone, painkillers, pills, prescription drug abuse, prescriptions
Leave a comment
Cardinal loses round in DEA painkiller distribution fight
A federal judge has ruled that the Drug Enforcement Administration can block Cardinal Health from distributing controlled substances from one of its Florida facilities. Earlier this month, the DEA suspended Cardinal’s license after finding that the company – which is one of the nation’s largest distributors of pharmaceuticals – sold excessive amounts of oxycodone to four Florida pharmacies. (The suspension relates only to the company’s license to distribute controlled substances from its Lakeland, Fla. facility, which the DEA claims shipped 50 times as much oxycodone to its top four customers than it has shipped to its other Florida retail customers.)
Cardinal challenged the suspension in federal court, and both the company and the DEA filed documents that give an inside look into how prescription painkillers have flooded the black market.
Cardinal was granted a temporary restraining order blocking the suspension after convincing a different judge that the move would disrupt drug shipments to more than 2,500 pharmacy customers in Florida, Georgia and South Carolina. The company said it has “robust controls and performs careful due diligence,” noting that in the past four years, it has stopped shipping controlled medicines to more than 350 pharmacies it determined posed an unreasonable risk of diversion, including 160 in Florida alone.
Posted in Crime, Informational, Pharmaceutical Industry, Policy & Regulation
Tagged addiction, Big Pharma, Cardinal Health, DEA, opiates, opioid, oxycodone, pain medication, painkillers, pharmaceutical, pharmacy, pills, politics, prescription drug abuse, prescriptions, Schedule II narcotics
Leave a comment